IL-17 eliminates the therapeutic effects of myelin basic protein-induced nasal tolerance in experimental autoimmune encephalomyelitis by activating IL-6.

Source:http://linkedlifedata.com/resource/pubmed/id/19055697

Download in:

View as

General Info

PMID
19055697